Mergen Biologics Training And Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.35 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 37.63%
- Profit Growth 61.82%
- Ebitda 63.81%
- Net Worth -103.33%
- Total Assets 138.50%
About Mergen Biologics Training And Research
Mergen Biologics Training And Research Private Limited (MBTARPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 August 2019 (Five years and six months 12 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Education & Learing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.35 M, as per Ministry of Corporate Affairs (MCA) records.
Binita Baruah, Pojul Loying, Suranjoy Baruah, and One other member serve as directors at the Company.
Company Details
- Location
Kamrup, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U80904AS2019PTC019442
- Company No.
019442
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Education & Learing
Who are the key members and board of directors at Mergen Biologics Training And Research?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Binita Baruah  | Director | 19-Aug-2019 | Current |
| Pojul Loying | Director | 19-Aug-2019 | Current |
| Suranjoy Baruah | Director | 01-Jan-2024 | Current |
| Meenakshi Borbora | Director | 01-Sep-2024 | Current |
Financial Performance of Mergen Biologics Training And Research.
Mergen Biologics Training And Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 37.63% increase. The company also saw a substantial improvement in profitability, with a 61.82% increase in profit. The company's net worth observed a substantial decline by a decrease of 103.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mergen Biologics Training And Research?
Unlock access to Mergen Biologics Training And Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mergen Biologics Training And Research?
Unlock and access historical data on people associated with Mergen Biologics Training And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mergen Biologics Training And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mergen Biologics Training And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
